pharma news today obesity glp-1 drugs changed the conversation almost overnight. But the boom created a second market around compounded versions, online sales, and aggressive marketing that patients now have to navigate. According to a Harnessing GLP-1 Receptor Agonists for

Data on older, non-exercising people taking creatine shows that supplementation can delay muscle loss

Qsymia : In a 56-week trial, people lost an average of 10% of their starting weight on the highest dose (15 mg/92 mg)

Export PDF reports Create reports you can share with your doctor or healthcare provider

These results provide the first evidence that inhibiting the PI3K/Akt pathway attenuates CM-associated allodynia

Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2

Neither the Summary of Product Characteristics (SmPC) for Rybelsus nor major drug interaction databases identify ibuprofen as a contraindicated or significantly interacting medication